NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/08/2024
Voltar para busca
Dado oficial do USPTO
BIONORICA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIONORICA
ST13
US500000079070126Classe
3, 5, 16
Pedido
79070126
Registro
3870253
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
73
Atualização mais recente
01/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 16
Data de depósito
26/03/2009
Data de registro
02/11/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/12/2020
Última transação
15/12/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Neumarkt, DE
Examinador
LOTT, MAUREEN DALL
Unidade examinadora
M80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
B. S. (pessoa física)
B. S. (pessoa física)
Bionorica AG
Representantes
KENNETH F. FLOREK FLOREK & ENDRES PLLC
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 16
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Essential oils for use in the manufacture of cosmeticshair lotions and perfumery; hair lotions; dentifrices
Classe 5
Pharmaceutical preparations for use in the treatmentcuremitigation or prevention of gingivitishalitosisstomatitisperiodontitisinflammation of the oral cavity and pharyngeal cavityhypersensitivity of teethanginaatherosclerosisbronchial asthmacirculatory disordersconstipationdiarrheaheart failureheart rhythm disordershigh blood pressureindigestioninsomniamigrainemotion sicknessnauseapeptic ulcersvomitingallergygynecological disorders affecting menstruationsterilitymenstrual syndromesdysmenorrhoeainfertilitygenital tract infectionspelvic inflammatory diseasesvaginal discomfort due to menopausal atrophic changesanatomical abnormalities of the headthe extremitieschestabdomen and organsneoplasiabreast neoplasmbreast cancermastopathymastodyniapremenstrual syndromeclimacteric complaintsbreast painblood conditions and disordersblood circulation disordershigh blood pressurehypertensionpulmonary diseasesheart rhythm disordersheart failureurological diseasessexually transmitted diseases and inflammatory pelvic diseasesmenopausal complaints due to therapeutically induced menopausetamoxifen induced hot flushes of breast cancer survivorsclimactic sleep disturbancesdepressive moodsprotection of the skeletal systemosteoporosiscentral nervous system infectionsbrain diseasescentral nervous system movement disordersocular motility disordersspinal cord diseasespsycho vegetative disordersdepressive syndromeanxietynervous unrestperipheral nervous system infectionsperipheral nervous system movement disordersnerve compression syndromesneuritisneuralgia and regional pain syndromesdiseases and disorders of the kidneyurological disorderschronic infections of the bladdercystitispyelonephritisglomerulonephritisinterstitial nephritisnephrolithiasiscancerurolith prophylaxisdizzinessmigrainedepressioninflammations of the upper and lower respiratory organssinusesbronchitistonsillitisarthritisosteoarthritisfevercoughcoldAlzheimer's diseaseinfection of respiratory tractinfection of urinary tracturinary obstructionchronic venous insufficiencyprostate hyperplasiamuscle painssoft tissue rheumatismmusculoskeletal diseaseliver diseasehepatitiscirrhosis of liverperiodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressantdiuretichypnoticsedativeanaleptictranquilizer; haemorrhoidal ointmentlaxativenasal decongestant capsulesnasal spray preparationsnon-narcotic analgesicsthroat lozenges; medicinal preparations in tablet formmenstruation circulation regulating tablets; pharmaceutical preparationsfor hormone regulation and hormone replacement; pharmaceutical preparations for sensory organsfor use in ophthalmologyotolaryngology and dermatology ; pharmaceutical preparations for regulation and strengthening of the immune systempharmaceutical preparations for treating of and providing temporary relief for occasional minor irritationpainsore mouthsore gumssore throatpain associated with canker sorespain due to minor irritation or injury of the mouth and gumspain due to minor dental procedurespain due to minor irritations caused by dentures or orthodontic appliancessore gums due to teething in infants and children four months of age and older; pharmaceutical productsmedicated dentalgum and mouth washesmedicated dentalgum and mouth rinsemedicated toothpastesmedicated oral-care gelsmedicated dental gelsmedicated lozengescough lozengesmedicated chewing gummedicated gels and fluids in the nature of medicated balmsmedicated dental tapesmedicated dental ribbonsmedicated dental polish; pharmaceutical preparations for dental purposesplaque disclosing reagentsperiodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and cariesdiagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseasesdental cariescanker sorescold soresmucositis and oral and tongue cancers; medicated mouth spraysplant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygieneantisepticsoral antisepticsdisinfectants for health purposes; medicated sanitary preparations for the treatmentcleaning and protection of the skin; dietary supplements in the form of tabletsdropscapsulesextract preparationsbalms or in liquid formcontaining plant extracts; dietetic foods adapted for medical use in the form of tabletsdropscapsulesextract preparationsbalms or in liquid form; food for medically restricted dietsfood for diabeticsfood supplements containing plant extractsfood supplements derived from plants or plant extractsall aforesaid goods in the form of tabletsdropscapsulesextract preparationsbalms or in liquid form; vitamin and mineral supplements; food and food supplementsherbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; dietetic food supplementsdietary supplementsfood supplements and dietary food supplements; mineral food supplementsfood supplements based on amino acidsminerals and/or trace elementsmedical plasters; materials for dressingsgauze and bandages; all purpose disinfectantsmaterial for stopping teeth; dental wax
Classe 16
Paper; cardboard; goods made from paper and cardboardpaper bagscoastersworks of art in the nature of art prints; printed matterbooksmagazinesjournalsnewspapersperiodicalsleafletsmanualscatalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding materialbook bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materialsartists' pastelsartists' pencilsartists' penspainting sets for children; paint brushes; typewriters; office requisites except furniturepunchesstaplerserasersdesk padspencil sharpeners; instructional and teaching materialprinted instructional and teaching material in the field of medicine and phytopharmacy; paper bagsenvelopes and pouches for packagingplastic bags and bubble packs for packaging
Publicações
Histórico de despachos e eventos da marca no USPTO.
73 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/02/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/09/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
15/08/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
15/12/2020
71AG
REGISTERED-SEC.71 ACCEPTED
15/12/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2020
ES71
TEAS SECTION 71 RECEIVED
16/09/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/11/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/04/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/01/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/12/2017
INPC
INVALIDATION PROCESSED
07/12/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
29/11/2017
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
29/03/2017
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
29/03/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/03/2017
ES71
TEAS SECTION 71 RECEIVED
12/10/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/06/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2011
FIMP
FINAL DISPOSITION PROCESSED
11/02/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2010
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/09/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/08/2010
PUBO
PUBLISHED FOR OPPOSITION
17/08/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/07/2010
ALIE
ASSIGNED TO LIE
12/07/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2010
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
14/06/2010
GPRA
PRIORITY ACTION E-MAILED
14/06/2010
CPRA
PRIORITY ACTION WRITTEN
14/06/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
07/06/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/06/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
07/06/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/06/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/05/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2010
ALIE
ASSIGNED TO LIE
28/05/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2010
NAUD
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
14/04/2010
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
13/04/2010
ACEC
AMENDMENT FROM APPLICANT ENTERED
26/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2010
FAXX
FAX RECEIVED
24/03/2010
FAXX
FAX RECEIVED
23/03/2010
NAUD
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
26/02/2010
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
26/02/2010
ACEC
AMENDMENT FROM APPLICANT ENTERED
26/02/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2010
ALIE
ASSIGNED TO LIE
23/02/2010
PAPER RECEIVED
25/01/2010
RFNT
REFUSAL PROCESSED BY IB
03/10/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/08/2009
RFRR
REFUSAL PROCESSED BY MPU
03/08/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/08/2009
CNRT
NON-FINAL ACTION WRITTEN
31/07/2009
MAFR
APPLICATION FILING RECEIPT MAILED
28/07/2009
DOCK
ASSIGNED TO EXAMINER
24/07/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/07/2009
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
23/07/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/07/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIONORICA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.